Compare METC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | METC | AMPH |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | 900 | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 790.3M | 885.4M |
| IPO Year | N/A | 2005 |
| Metric | METC | AMPH |
|---|---|---|
| Price | $11.82 | $19.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $34.00 | $28.38 |
| AVG Volume (30 Days) | ★ 1.5M | 542.4K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $19.61 | $6.90 |
| Revenue Next Year | $11.96 | $4.64 |
| P/E Ratio | ★ N/A | $140.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.20 | $16.65 |
| 52 Week High | $57.80 | $31.26 |
| Indicator | METC | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 38.57 | 50.94 |
| Support Level | $11.34 | $18.12 |
| Resistance Level | $13.68 | $19.81 |
| Average True Range (ATR) | 0.83 | 0.71 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 20.79 | 61.88 |
Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.